1. Home
  2. INBX vs SCL Comparison

INBX vs SCL Comparison

Compare INBX & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$72.00

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Stepan Company

SCL

Stepan Company

HOLD

Current Price

$51.67

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
INBX
SCL
Founded
2010
1932
Country
United States
United States
Employees
161
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Package Goods/Cosmetics
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
INBX
SCL
Price
$72.00
$51.67
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
218.5K
180.6K
Earning Date
11-14-2025
02-18-2026
Dividend Yield
N/A
3.06%
EPS Growth
N/A
N/A
EPS
N/A
1.98
Revenue
$1,400,000.00
$2,303,837,000.00
Revenue This Year
$563.00
$8.79
Revenue Next Year
N/A
$8.14
P/E Ratio
N/A
$26.07
Revenue Growth
N/A
5.35
52 Week Low
$10.81
$41.82
52 Week High
$94.57
$65.89

Technical Indicators

Market Signals
Indicator
INBX
SCL
Relative Strength Index (RSI) 41.77 70.99
Support Level $69.47 $46.70
Resistance Level $76.47 $52.61
Average True Range (ATR) 4.77 1.27
MACD -0.76 0.26
Stochastic Oscillator 20.55 81.22

Price Performance

Historical Comparison
INBX
SCL

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Share on Social Networks: